Cellectis CLLS
NASDAQ CLLS
$1.40 -0.11 (-7.28%)
At close: Oct 1, 2026 · 4:00 PM EDT

Cellectis (CLLS) Accumulated Expenses (2016 - 2024)

Updated

Cellectis' Accumulated Expenses was $8.83 million in Q4 2024, down 5.7% from $9.37 million a year earlier.

Analysis

Cellectis (CLLS) Accumulated Expenses (2016 - 2024) Analysis & Trends

From Q4 2016 onward, Cellectis has reported Accumulated Expenses for 9 quarters.

  • Accumulated Expenses shows a three-year compound annual growth rate of 196.4% (FY2021 to FY2024).
  • In earlier years, Accumulated Expenses was $9.37 million in FY2023 (-0.6%), $9.42 million in FY2022 and $339,000 in FY2021.
  • Quarterly Accumulated Expenses has moved between $339,000 (Q4 2021) and $9.42 million (Q4 2022) over five years.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Cellectis 151.51 Mn -601.88 Mn -
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2024 8.83 Mn
Jun 30, 2024 6.97 Mn
Dec 31, 2023 9.37 Mn
Dec 31, 2022 9.42 Mn
Mar 31, 2022 379,000.00
Dec 31, 2021 339,000.00
Dec 31, 2018 7.04 Mn
Dec 31, 2017 5.98 Mn
Dec 31, 2016 4.14 Mn
API Access

Cellectis Accumulated Expenses API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=accumulated-expenses&ticker=CLLS&period=max&api_key=YOUR_API_KEY